Latest Kaiser Health News Stories
The polarizing abortion issue threatens to tie up Congress, the Supreme Court and the states for the coming year. Meanwhile, Congress kicks the can down the road to December on settling its spending priorities. Joanne Kenen of Politico and the Johns Hopkins School of Public Health, Yasmeen Abutaleb of The Washington Post and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more.
Also this week, Rovner interviews KHN’s Aneri Pattani, who delivered the latest KHN-NPR “Bill of the Month” episode about a covid test that cost as much as a luxury car.
Dr. Francis Collins, who announced he is stepping down as chief of the National Institutes of Health, used his communication skills and political insights to help protect the highly acclaimed federal research institutes through difficult times.
KHN’s Sarah Jane Tribble and Arthur Allen join Science Friday host Ira Flatow to recap the evolving news in the run-up to offering booster shots for the covid vaccine.
With real-time data streaming in from highly specialized researchers in the U.S. and abroad, NIH scientists became convinced that boosting the covid-19 vaccine was needed to save lives, prompting the president to announce a plan with a Sept. 20 start date. Scientists at the regulatory agencies weren’t yet convinced. A meeting Friday will determine what happens next. Here’s the story from behind the scenes.
A raft of startups are charging consumers hundreds of dollars to analyze the microbes in their gut and offer dietary advice based on the results. But scientists say scant research has been done, and as customers of one company have learned the hard way, the experience isn’t always smooth.
Aduhelm, approved by the Food and Drug Administration last month despite questions about its efficacy, could be prescribed to at least 1 million patients a year, for a price tag of about $56 billion. Experts suggest there might be better ways to spend that money.
Exclusive: The head of the National Institute of Allergy and Infectious Diseases says health workers ‘have lived up to the oath they take’ but says shortages of protective gear have contributed to excess deaths.
Hay medicamentos aprobados hace años que podrían investigarse en profundidad para tratar covid. Pero no hay interés porque no generarían grandes ganancias.
Philanthropies are funding studies of cheap, existing medications like the antidepressant fluvoxamine as covid treatments. But early hype about hydroxychloroquine and other repurposed drugs leaves researchers leery of hasty conclusions.
In his campaign, President Joe Biden promised to undo policies, particularly health policies, implemented by former President Donald Trump. Yet, despite immense executive power, reversing four years of action takes time and resources.
Muchos de los principales especialistas en enfermedades infecciosas subestimaron el veloz brote en sus primeras semanas y meses, asumiendo que Estados Unidos, otra vez, saldría ileso.
Scientists learned the wrong lesson from past outbreaks, but Dr. Anthony Fauci doesn’t cast blame.
It’s no worse than the flu, and other deadly disinformation about the coronavirus
El doctor Anthony Fauci, la autoridad máxima en enfermedades infecciosas del país, dice que, si la mayoría de las personas se vacuna, se lograría cierta “normalidad” a mediados de 2021.
In a new interview, the nation’s top infectious disease expert tells us how to survive the coming months and describes how hard it is when people still insist the coronavirus outbreak is “fake news.”
Anthony Fauci is one of the nation’s most trusted voices during public health emergencies. As the head of the National Institutes of Health’s National Institute of Allergy and Infectious Diseases since 1984, Fauci has helped guide the nation through the HIV/AIDS epidemic and more recent outbreaks of Ebola and Zika. In this special episode of KHN’s “What the Health?” podcast, Fauci sits down with KHN Editor-in-Chief Elisabeth Rosenthal to talk about how to navigate the next phase of the coronavirus pandemic and what the incoming Biden administration should do first.
Drugmakers will walk away with massive profits, but much of the pioneering work on mRNA vaccines was done with government money.
Muchos pacientes desconocen estas opciones o simplemente no pueden, o no saben, cómo acceder a ellas. Otros desconfían de los tratamientos no probados.
If you or a loved one has COVID-19, here’s what to consider before seeking experimental treatments.
Data and safety monitoring boards work under a cloak of secrecy meant to prevent undue influence by stakeholders, such as companies or the government. In the Trump era, some worry the anonymity could actually invite it.